Tapentadol differs from tramadol in that tapentadol produces its analgesia through which combination of mechanisms, without requiring metabolic activation?

• A Direct mu-opioid receptor agonism and norepinephrine reuptake inhibition (NRI), no serotonin reuptake inhibition ✓
• B Prodrug activated to O-desmethyltramadol (mu agonist) and inhibitor of serotonin/norepinephrine reuptake
• C Selective mu agonism only, with partial delta-opioid receptor antagonism reducing tolerance
• D Mu agonism, serotonin reuptake inhibition, and norepinephrine reuptake inhibition simultaneously

Explanation

Tapentadol directly (not via a metabolite) acts as a mu-opioid receptor agonist AND as a norepinephrine reuptake inhibitor. It does NOT significantly inhibit serotonin reuptake, which distinguishes it from tramadol and reduces the risk of serotonin syndrome. Tramadol is a prodrug; its active metabolite O-desmethyltramadol is the primary mu agonist and requires CYP2D6 activation. Tapentadol's analgesic potency comes from synergistic mu-opioid + spinal norepinephrine (descending inhibition) mechanisms, providing effective analgesia for neuropathic pain with lower mu-opioid burden and reduced constipation/nausea compared to equipotent opioids.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.